Pamela Yarrington
Physician Assistant · Lake Mary, FLNPI 1821133935
Payments from drug & device makers
Across 260 payments — averaging $23.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$696
- Johnson & Johnson$672
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$531
- Teva Pharmaceuticals USA, Inc.$469
- E.r. Squibb & Sons, L.L.C.$445
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,120100%
- Education$270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$248
- Austedo XR$242
- VRAYLAR$242
- INVEGA SUSTENNA$131
- COBENFY$128
- SPRAVATO$125
- Auvelity$122
- INGREZZA$122
- ABILIFY MAINTENA$118
- JORNAY PM$116
- Dyanavel XR$114
- Quillivant$114
- Quillichew ER$114
How this compares
$6,147 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 21 | $73,231 |
| TrintellixVortioxetine Hydrobromide | 68 | $45,072 |
| RexultiBrexpiprazole | 11 | $29,986 |
| LatudaLurasidone Hcl | 15 | $29,618 |
| Lurasidone Hcl | 33 | $4,866 |
| Aripiprazole | 80 | $3,782 |
| Oxcarbazepine | 14 | $3,060 |
| Quetiapine Fumarate | 181 | $2,958 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 59 | $2,482 |
| Mirtazapine | 130 | $2,354 |
| Duloxetine Hcl | 88 | $2,167 |
| Vilazodone Hcl | 17 | $2,134 |
| Carbamazepine ErCarbamazepine | 24 | $2,005 |
| Buspirone Hcl | 175 | $1,764 |
| Trazodone Hcl | 154 | $1,708 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $672 | $73,23121 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $134 | $45,07268 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $696 | $29,98611 claims |
| Sunovion Pharmaceuticals Inc.Latuda | $80 | $29,61815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Lake Mary
- Linda NewLake Mary$179K
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.